Adverse Drug Events Recruiting Phase 4 Trials for Cyclopentolate (DB00979)

Also known as: Adverse Drug Event

IndicationStatusPhase
DBCOND0029335 (Adverse Drug Events)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03638726Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in PhacoemulsificationOther